Gene: ORAI3
Official Full Name: ORAI calcium release-activated calcium modulator 3provided by HGNC
Gene Summary: Enables store-operated calcium channel activity. Involved in store-operated calcium entry. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08101 | ORAI3 Knockout cell line (HeLa) | Human | ORAI3 | 1:3~1:6 | Negative | Online Inquiry |
KO08102 | ORAI3 Knockout cell line (HCT 116) | Human | ORAI3 | 1:2~1:4 | Negative | Online Inquiry |
KO08103 | ORAI3 Knockout cell line (HEK293) | Human | ORAI3 | 1:3~1:6 | Negative | Online Inquiry |
KO08104 | ORAI3 Knockout cell line (A549) | Human | ORAI3 | 1:3~1:4 | Negative | Online Inquiry |
ORAI3 Gene Knockout Cell Lines are specialized cellular models designed to facilitate the study of the ORAI3 gene, which encodes a calcium release-activated calcium (CRAC) channel essential for various cellular processes, including muscle contraction, immune response, and cellular signaling. These cell lines are generated using advanced CRISPR/Cas9 genome-editing technology, allowing for precise and efficient disruption of the ORAI3 gene, thereby creating a controlled environment in which researchers can assess the direct impact of ORAI3 on calcium signaling and associated physiological responses.
The primary function of ORAI3 Gene Knockout Cell Lines lies in their ability to provide insight into the physiological and pathological roles of ORAI3 in different cell types. By studying these knockout cell lines, researchers can investigate the mechanisms through which ORAI3-mediated calcium influx influences cell behavior and contributes to disease states. This has significant implications for understanding conditions such as immune disorders, muscle diseases, and neurodegenerative diseases, where calcium signaling plays a critical role.
Scientifically, these cell lines serve as invaluable tools in both basic and applied research settings. They enable researchers to explore the underlying mechanisms of calcium homeostasis and signaling in a targeted manner, laying the foundation for potential therapeutic interventions. The ability to create a controlled knockout model allows for more accurate experimental outcomes and the exploration of synergistic effects with other signaling pathways or treatments.
One unique selling point of the ORAI3 Gene Knockout Cell Lines is their specificity and versatility. Compared to traditional knockout methods, which may result in off-target effects, the precision of CRISPR/Cas9 genome editing ensures that researchers can confidently attribute observed phenotypic changes directly to the inactivation of the ORAI3 gene. Furthermore, these cell lines can be utilized across various cell types, amplifying their applicability in different research areas.
For researchers and clinicians alike, the value of ORAI3 Gene Knockout Cell Lines cannot be overstated. They offer a robust platform for unraveling the complexities of calcium signaling networks, potentially leading to innovative strategies for treatments that target calcium-related disorders.
Our company specializes in providing high-quality, genetically modified cell lines and is committed to advancing research with reliable and innovative solutions. The ORAI3 Gene Knockout Cell Lines are a testament to our expertise in developing tools that cater to the evolving needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.